neoadjuvant multi-agent chemotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for neoadjuvant multi-agent chemotherapy, covering 2023-09-21 to 2023-09-21. Get the full timeline:
Most recent: Clinical Trial Update: NeoadjuVAnt muLti-agENT Chemotherapy or Patritumab Deruxtecan With or Without endocrINE Therapy for High-risk HR+/HER2- Breast Cancer - VALENTINE Trial [Phase 2]